Piramal Enterprises
CORPORATE /PHARMA Piramal Enterprises’ Healthcare vertical announces strategic alliance with Fujifilm Diosynth Biotechnologies for production of Antibody Drug Conjugates Mumbai; 29 th October 2012: Piramal Enterprises’ healthcare vertical recently has announced that it has entered into a strategic alliance with Fujifilm Diosynth Biotechnologies, whereby the two parties will offer the seamless contract development and manufacture of antibody drug conjugates (ADCs), a growing niche in the development of biopharmaceuticals. The deal will allow customers to benefit from the experience and assets of both organisations, while simplifying the supply chain and vendor management relationships, leading to shorter time to clinic. Piramal is a world leader in antibody drug conjugation, whilst Fujifilm Diosynth Biotechnologies is one of the world’s leading providers of contract development and manufacturing services for biopharmaceuticals. The combined experience covers work...